The world is currently experiencing the devastating effects of the coronavirus disease 2019 (COVID-19) pandemic caused by the newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
COVID-19 has severely challenged the health care systems in most countries around the world, with increased demand for rapid diagnosis and treatment of seriously ill patients.
28,274-29,533), spike (S, nt 21,563-25,384) and open reading frame 1ab (ORF1ab, nt 266-13,467) of SARS-CoV-2 WA1 strain (GenBank accession number MN985325.1) were designed and manufactured by a commercial company (Advanced Cell Diagnostics [ACD], Newark, CA; TableÂ 1).